Olema Pharmaceuticals (OLMA) EPS (Basic) (2020 - 2026)
Olema Pharmaceuticals' (OLMA) quarterly EPS (Basic) came in at -$1.41 in Q1 2026, down 280.74% year-on-year from $0.78 in Q1 2025, and down 166.54% on a QoQ basis from -$0.53 in Q4 2025.
Olema Pharmaceuticals (OLMA) EPS (Basic) (2020 - 2026) Analysis & Trends
Olema Pharmaceuticals (OLMA) has 7 years of EPS (Basic) data on file, last reported at -$1.41 in Q1 2026.
- On a quarterly basis, EPS (Basic) fell 280.74% year-over-year to -$1.41 in Q1 2026; TTM through Mar 2026 was -$2.72, a 9.6% decrease from a year earlier, with the FY2025 full-year figure at -$4.58, down 96.07% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$1.41, down from -$0.53 in the prior quarter.
- Over the last five years, EPS (Basic) for OLMA reached as high as -$0.37 in Q1 2025 and fell as low as -$1.68 in Q3 2023.
- Historically, EPS (Basic) has averaged -$0.88 across 5 years, with a median of -$0.67 in 2022.
- Across the five-year window, EPS (Basic) jumped 78.5% in 2022 and tumbled 280.74% in 2026, its largest moves.
- Year by year, EPS (Basic) stood at -$0.66 in 2022, then gained by 9.75% to -$0.6 in 2023, then grew by 4.09% to -$0.58 in 2024, then rose by 7.91% to -$0.53 in 2025, then plunged by 166.54% to -$1.41 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$1.41 in Q1 2026, -$0.53 in Q4 2025, and -$0.5 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Olema Pharmaceuticals | 1.21 Bn | 1.21 Bn | - | -1.41 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.41 |
| Dec 31, 2025 | -0.53 |
| Sep 30, 2025 | -0.50 |
| Jun 30, 2025 | -0.54 |
| Mar 31, 2025 | -0.37 |
| Dec 31, 2024 | -0.58 |
| Sep 30, 2024 | -1.38 |
| Jun 30, 2024 | -1.20 |
| Mar 31, 2024 | -1.29 |
| Dec 31, 2023 | -0.60 |
| Sep 30, 2023 | -1.68 |
| Jun 30, 2023 | -1.27 |
| Mar 31, 2023 | -0.75 |
| Dec 31, 2022 | -0.66 |
| Sep 30, 2022 | -0.64 |
| Jun 30, 2022 | -0.91 |
| Mar 31, 2022 | -0.67 |
| Dec 31, 2021 | -0.55 |
| Sep 30, 2021 | -0.45 |
| Jun 30, 2021 | -2.47 |